C.R. BARD, INC. (BASD) -3006260740

Manufacturer adverse-event records for C.R. BARD, INC. -3006260740 come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2015–2026 · heavy-book · typical Death-code · balanced

Volume signature

C.R. BARD, INC. -3006260740 sits in the heavy MAUDE book

C.R. BARD, INC. (BASD) -3006260740 accounts for 39,065 FDA MAUDE reports (#91 of 443, heavy-book tercile). Death-coded event_type share is 0.58% (typical); Injury share 21.2% (balanced).

What the volume reading shows for C.R. BARD, INC. (BASD) -3006260740

The standout signal for C.R. BARD, INC. (BASD) -3006260740 is filing volume: 39,065 adverse-event reports in FDA MAUDE (#91 of 443, heavy-book). Death-coded event_type share sits at 0.58% (typical).

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair C.R. BARD, INC. -3006260740 with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 20 device types, led in this extract by Malfunction at 30,549 (78.2% of event_type total). Peak single-year volume reaches 10,677 reports across 8 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

39,065
Total Reports
228
Event-type Death
8,288
Injury Reports
20
Device Types

Event Types

Malfunction 30,549 (78.2%)
Injury 8,288 (21.2%)
Death 228 (0.6%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Other 22,754 (58.0%)
8,125 (20.7%)
Required Intervention 7,373 (18.8%)
Life Threatening 493 (1.3%)
Death 212 (0.5%)
R 136 (0.3%)
O 66 (0.2%)
L 26 (0.1%)
D 24 (0.1%)
Hospitalization 6 (0.0%)
Congenital Anomaly 1 (0.0%)

Yearly Trend

15
2015: 10
20
2020: 1,074
21
2021: 5,262
22
2022: 6,142
23
2023: 6,106
24
2024: 8,170
25
2025: 10,677
26
2026: 1,624